Data-driven strategies for effective pharmacy management — with a spotlight on GLP-1s

Pharmacy costs continue to climb each year, influenced by the introduction of innovative therapies, growing consumer demand, and changing federal regulations. For plan sponsors, the increased use of glucagon-like peptide-1 (GLP-1) medications presents ongoing financial challenges, especially as manufacturers pursue expanded indications for these drugs beyond diabetes and weight management.

Join Milliman MedInsight experts as they share how advanced analytics can empower your organization to develop more effective pharmacy management strategies. In this webinar, we’ll demonstrate how reliable analytics can identify the key drivers behind rising pharmacy drug utilization and costs and reveal actionable opportunities to optimize outcomes and improve value.

Topics include:

• The primary factors contributing to increased pharmacy drug utilization and costs
• How advanced analytics can support smarter, data-driven decisions to enhance clinical and financial outcomes
• Strategies for managing specialty pharmacy drug costs by understanding the distinctions between medical benefit and pharmacy benefit coverage
• Effective strategies for overseeing high-cost, widely utilized pharmacy drugs such as GLP-1s

Plus, you’ll also get a first look at new innovations in GLP-1 benchmarking and cost impact reporting, available through the Milliman MedInsight Innovation Portal, with an extension to Power BI, to help you make smarter, faster decisions around high-cost drug management.

Don’t miss this opportunity to gain valuable insights to strengthen your pharmacy management strategies with data-driven solutions.

Register now to be the first to access this insightful session when it goes live.

Presenters